Actively Recruiting
Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
Led by Lars Hvid · Updated on 2025-05-04
64
Participants Needed
2
Research Sites
139 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The overall purpose of this project is to develop and test an infrastructure that can ensure early and specialized rehabilitation for individuals with multiple sclerosis (MS) on their path to recovery from a relapse. If this project proves successful, it can therefore help optimize clinical practice and provide a significant contribution to the treatment of relapsing-remitting sclerosis.
CONDITIONS
Official Title
Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Admitted to the Danish MS Hospitals for an inpatient rehabilitation stay
- Confirmed motor relapse within the past 6 months by a neurologist
- Disability or functional interference with change in pyramidal and/or cerebellar scores of 2 or higher
- Completed steroid or other acute relapse treatment if prescribed
- Age over 18 years
You will not qualify if you...
- More than 6 months since onset of motor relapse
- Medical conditions or substantial cognitive impairments that hinder participation (e.g., inability to perform or understand the intensive rehabilitation)
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The Danish MS Hospitals
Haslev, Denmark, 7080
Actively Recruiting
2
The Danish MS Hospitals
Ry, Denmark, 7080
Actively Recruiting
Research Team
L
Lars Hvid, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here